These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
34. Prostate specific antigen testing for prostate cancer. Thornton H; Dixon-Woods M BMJ; 2002 Oct; 325(7367):725-6. PubMed ID: 12364286 [No Abstract] [Full Text] [Related]
35. Prostate-specific antigen and the early diagnosis of prostate cancer. Caplan A; Kratz A Am J Clin Pathol; 2002 Jun; 117 Suppl():S104-8. PubMed ID: 14569806 [TBL] [Abstract][Full Text] [Related]
36. Prostate-cancer screening--what the U.S. Preventive Services Task Force left out. Brett AS; Ablin RJ N Engl J Med; 2011 Nov; 365(21):1949-51. PubMed ID: 22029759 [No Abstract] [Full Text] [Related]
38. Possibility of re-screening intervals of more than one year in men with PSA levels of 4.0 ng/ml or less. Ito K; Yamamoto T; Ohi M; Takechi H; Kurokawa K; Suzuki K; Yamanaka H Prostate; 2003 Sep; 57(1):8-13. PubMed ID: 12886518 [TBL] [Abstract][Full Text] [Related]
39. Characteristics of screening detected prostate cancer in men 50 to 66 years old with 3 to 4 ng./ml. Prostate specific antigen. Lodding P; Aus G; Bergdahl S; Frösing R; Lilja H; Pihl CG; Hugosson J J Urol; 1998 Mar; 159(3):899-903. PubMed ID: 9474178 [TBL] [Abstract][Full Text] [Related]